News Daily News Long-term Watchman Data Reassure: CAP and CAP2 Registries Michael O'Riordan December 02, 2019
News Daily News Anticoagulant Type May Influence Fracture Risk in A-fib Patients Todd Neale October 21, 2019
News Daily News Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome Todd Neale October 15, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News ESC 2019 ESC Updates Guidance on Management of Acute Pulmonary Embolism Todd Neale September 06, 2019
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Daily News DOACs Good for Secondary Prevention in Older A-fib Patients, Real-world Numbers Affirm Todd Neale July 23, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Industry News Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation May 22, 2019
News Conference News HRS 2019 Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib Todd Neale May 17, 2019
News Daily News DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit Todd Neale March 12, 2019
News Daily News High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin Shelley Wood March 08, 2019
News Daily News DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight Todd Neale February 25, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019